Physician profile
Tung Tran
NPI 1982788337
$1,146.97
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2020: $201 · 2021: $112 · 2022: $85.73 · 2023: $191 · 2024: $85.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $256 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.76 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $227.64 | 2022-2023 | |
| Allergan, INC. | $177.26 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $147.68 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $104.66 | 2020 | |
| Glaxosmithkline, LLC. | $100.62 | 2019-2023 | Trelegy Ellipta |
| Itamar Medical INC | $81.41 | 2023-2024 | Watchpatone |
| Boehringer Ingelheim Pharmaceuticals, INC. | $65.94 | 2021 | |
| Mylan Specialty L.P. | $43.98 | 2019-2020 | |
| Shire North American Group INC | $39.73 | 2019 | |
| Philips North America LLC | $24.77 | 2019 | |
| Covidien LP | $23.62 | 2019 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Veran Medical Technologies, INC. | $18.34 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.97 | 2021 | |
| Nabriva Therapeutics, Plc | $16.46 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $14.07 | 2019 | |
| Electromed, INC. | $12.87 | 2021 | |
| Chiesi USA, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tung Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.